1 workflow in this folder and its subfolders
April 2023 · Using VAERS for pharmacovigilance of special populations U.S. Food and Drug Administration (FDA) and drug manufacturers regularly monitor a drug's adverse events during clinical trials and post FDA approval. Post-marketing surveillance is important because there is a greater diversity in patients ta…